Squalene synthase inhibitors: their potential as hypocholesterolaemic agents.
Watson
N S
NS
Medicinal Chemistry 3 Department, Glaxo Wellcome Medicines Research Centre, Stevenage, Hertfordshire, U.K.
Procopiou
P A
PA
D000818:Animals; D000924:Anticholesteremic Agents / Q000737:chemistry; D013186:Farnesyl-Diphosphate Farnesyltransferase / Q000037:antagonists & inhibitors*; D006801:Humans; D015394:Molecular Structure; D051381:Rats; D013329:Structure-Activity Relationship
D000924:Anticholesteremic Agents; D013186:Farnesyl-Diphosphate Farnesyltransferase